missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human IL-29 (IFN lambda-1), AOF Recombinant Protein
Click to view available options
Quantity:
1 mg
100 μg
500 μg
Unit Size:
100µg
1mg
500µg
Description
IFN-lambdas constitute a novel family of interferons that mediate the induction of anti-viral protection in a wide variety of cells. There are three members in this family, namely lambda1, lambda2, and lambda3, which are also known as IL-29, IL-28A, and IL-28B, respectively. Similar to type I IFNs, IFN-lambdas activate an intracellular signaling to promote gene expression. IFN-lambdas mediate their anti-viral protection through a class II cytokine receptor complex composed of two essential receptor proteins, CRF2-12/IFN-lambdaR1, which is unique to IFN-lambdas, and CFR2-4/IL-10R2, which is shared with IL-10, IL-22, and IL-26 receptors. The IFN-lambdas, IL-28 and IL-29, have recently been reported to prime dendritic cells to induce proliferation of Foxp3-bearing regulatory T cells. DCs that differentiate in response to IFN-lambdas express high levels of class I and II MHC gene products, but low levels of costimulatory molecules. Moreover, these cells can specifically induce IL-2-dependent proliferation of CD4+CD25+FOXP3+ T cells with contact-dependent suppressive activity.
- Purity: >95% by SDS-Page
- Endotoxin Concentration: AX41 ≤EUs/μg
- Protein Length: 179 aa.
- Molecular Weight: 19.9 kDa
- Animal Origin Free: Yes
Specifications
Specifications
| Accession Number | Q8IU54 |
| For Use With (Application) | Control, ELISA, Gel Shift, Western Blot |
| Formulation | 0.1% TFA with no preservative |
| Gene ID (Entrez) | 282618 |
| Molecular Weight (g/mol) | 19.9 kDa |
| Name | Human IL-29, AOF |
| Quantity | 1 mg |
| Source | E. coli |
| Storage Requirements | -20°C |
| Regulatory Status | RUO |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction